PromarkerD test ready for launch in Europe

Proteomics International completes technology transfer of PromarkerD to clinical diagnostics partner Atturos.

Atturos to make the mass spectrometry version of PromarkerD available to licence partners in the European market.

The PromarkerD test system is the first test globally that is capable of predicting the onset of diabetic kidney disease.

Media Release